Body shape and composition in HIV-infected women: An urban cohort

HIV Medicine

Volumn 6, Issue 4, 2005, Pages 245-252

  Karmon, S L ^a   Moore, R D ^a,b   Dobs, A S ^a   Keruly, J ^a,b,c   Barnett, S ^d   Cofrancesco Jr , Joseph ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e JHOC 7155 ^*  (United States)

Author keywords

AIDS; Body composition; HIV; Lipodystrophy; Obesity; Wasting; Women

Indexed keywords

ANTIRETROVIRUS AGENT; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG;

ACADEMIC ACHIEVEMENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTHROPOMETRY; BIOENERGY; BODY BUILD; BODY COMPOSITION; BODY FAT; COHORT ANALYSIS; DISEASE DURATION; FEMALE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIPODYSTROPHY; MAJOR CLINICAL STUDY; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELF REPORT; UNITED STATES; URBAN AREA; WASTING SYNDROME; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; ELECTRIC IMPEDANCE; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; TIME FACTORS; URBAN HEALTH; VIRAL LOAD;

EID: 22644439536     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2005.00284.x     Document Type: Review

References (38)

1. Nahlen BL, Chu SY, Nwanyanwu OC, Berkelman RL, Martinez SA, Rullan JV. HIV wasting syndrome in the United States. AIDS 1993; 7: 183-188.
2. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31: 803-805.
3. Smit E, Skolasky RL, Dobs AS et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-99. Am J Epidemiol 2002; 156: 211-218.
4. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 230-236.
5. Kotler D, Wang J, Pierson RJ. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985; 42: 1255.
6. Kotler D, Engelson E, Thea D. Different body composition changes in men and women with AIDS. Eleventh International Conference on AIDS. Vancouver, Canada, July 1996 [Abstract].
7. Grinspoon S, Corcoran C, Miller K et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 1997; 82: 1332-1337.
8. Swanson B, Hershow RC, Sha BE, Benson CA, Cohen M, Gunfeld C. Body composition in HIV-infected women. Nutrition 2000; 16: 1064-1068.
9. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 43-48.
10. Carr A, Samaras K, Chisholm DJ, Cooper DA. Abnormal fat distribution and use of protease inhibitors. Lancet 1998; 351: 1736.
11. Silva M, Skolnik PR, Gorbach SL et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12: 1645-1651.
12. Carr A, Emery S, Law M et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003; 361: 726-735.
13. Puls RL, Carr A. Practical applications of the HIV lipodystrophy case definition. AIDS Read 2003; 13: 480-493.
14. Forrester JE, Gorbach SL. Fat distribution in relation to drug use, human immunodeficiency virus (HIV) status, and the use of antiretroviral therapies in Hispanic patients with HIV infection. Clin Infect Dis 2003; 37: S62-S68.
15. Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996; 12: 496-501.
16. Muurahainen N, Mulligan K. Clinical trials update in human immunodeficiency virus wasting. Semin Oncol 1998; 25: 104-111.
17. Galli M, Cozzi-Lepri A, Ridolfo AL et al. Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study. Arch Intern Med 2002; 162: 2621-2628.
18. Galli M, Ridolfo AL, Adorni F et al. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy. Antivir Ther 2003; 8: 347-354.
19. Galli M, Veglia F, Angarano G et al. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34: 58-61.
20. Thiebaut R, Daucourt V, Mercie P et al. Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine. Clin Infect Dis 2000; 31: 1482-1487.
21. Kumanyika SK. Minisymposium on obesity: overview and some strategic considerations. Annu Rev Public Health 2001; 22: 293-308.
22. Kumanyika SK. Special issues regarding obesity in minority populations. Ann Intern Med 1993; 119: 650-654.
23. Bowen DJ, Tomoyasu N, Cauce AM. The triple threat: a discussion of gender, class, and race differences in weight. Women Health 1991; 17: 123-143.
24. Savage PJ, Harlan WR. Racial and ethnic diversity in obesity and other risk factors for cardiovascular disease: implications for studies and treatment. Ethn Dis 1991; 1: 200-211.
25. Swanson B, Keithley J. Bioelectrical impedance analysis (BIA) in HIV infection: principles and clinical applications. J Assoc Nurs AIDS Care 1998; 9: 49.
26. York JL, Hirsch JA. Application of bioelectric impedance methodology and prediction equations to determine the volume of distribution for ethanol. Alcohol 1995; 12: 553-558.
27. Seidl S, Jensen U, Alt A. The calculation of blood ethanol concentrations in males and females. Int J Legal Med 2000; 114: 71-77.
28. National Center for HIV SaTPN, Division of HIV/AIDS Prevention (DHP). AIDS Public Information Data Set (APIDS). Atlanta, Centers for Disease Control and Prevention (CDC), 2004.
29. McComsey G, Maa JF. Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy. AIDS Read 2003; 13: 539-559.
30. Paton NI, Macallan DC, Jebb SA et al. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 119-127.
31. Heath KV, Chan KJ, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy. Int J Epidemiol 2002; 31: 1016-1020.
32. Seminari E, Tinelli C, Minoli L et al. Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients. Antivir Ther 2002; 7: 175-180.
33. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353: 2093-2099.
34. Carter VM, Hoy JF, Bailey M, Colman PG, Nyulasi I, Mijch AM. The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition. HIV Med 2001; 2: 174-180.
35. Aghdassi E, Tam C, Liu B et al. Body fat of older adult subjects calculated from bioelectric impedance versus anthropometry correlated but did not agree. J Am Diet Assoc 2001; 101: 1209-1212.
36. Wagner GJ, Ferrando SJ, Rabkin JG. Psychological and physical health correlates of body cell mass depletion among HIV + men. J Psychosom Res 2000; 49: 55-57.
37. Sluys TE, van der Ende ME, Swart GR, van den Berg JW, Wilson JH. Body composition in patients with acquired immunodeficiency syndrome: a validation study of bioelectric impedance analysis. JPEN J Parenter Enteral Nutr 1993; 17: 404-406.
38. Niyongabo T, Melchior JC, Henzel D, Bouchaud O, Larouze B. Comparison of methods for assessing nutritional status in HIV-infected adults. Nutrition 1999; 15: 740-743.